Skip to content
healthcare.dev

Cetacaine Topical Anesthetic

NDC 10223-0221, Benzocaine, Butamben, and Tetracaine Hydrochloride, gel, from Cetylite Industries, Inc..

Product NDC
10223-0221
Status
Listed
Labeler
Cetylite Industries, Inc.
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
UNAPPROVED DRUG OTHER
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/10223-0221 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BENZOCAINE.028 g/.2g
  • BUTAMBEN.004 g/.2g
  • TETRACAINE HYDROCHLORIDE.004 g/.2g

Pharmacologic classes

Allergens [CS]; Cell-mediated Immunity [PE]; Ester Local Anesthetic [EPC]; Esters [CS]; Increased Histamine Release [PE]; Local Anesthesia [PE]; Standardized Chemical Allergen [EPC]

Package NDCNDC-11Package
10223-0221-1102230221011 JAR in 1 BOX (10223-0221-1) / 32 g in 1 JAR

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/9777acbb-8166-4734-9932-dc66b05bfcb5

Use it

Look up 10223-0221 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/10223-0221 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 10223-0221. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.